Back to User profile » Dr Yi Cheng

Papers published by Dr Yi Cheng:


Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer

Ren T, Shan J, Li M, Qing Y, Qian C, Wang G, Li Q, Lu G, Li C, Peng Y, Luo H, Zhang S, Yang Y, Cheng Y, Wang D, Zhou SF

Drug Design, Development and Therapy 2015, 9:2887-2910

Published Date: 8 June 2015

Functional analysis of tanshinone IIA that blocks the redox function of human apurinic/apyrimidinic endonuclease 1/redox factor-1

Sui J, Li M, Qian C, Wang S, Cheng Y, Chen BP, Wang D

Drug Design, Development and Therapy 2014, 8:2147-2160

Published Date: 3 November 2014

Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor

Qian CY, Li MX, Sui JD, Ren T, Li Z, Zhang L, Zhou LW, Cheng Y, Wang D

Drug Design, Development and Therapy 2014, 8:485-496

Published Date: 9 May 2014